PCSK9 Inhibitors Linked to Better Survival in Some Cancer Patients on Immunotherapy
(MedPage Today) -- Use of a PCSK9 inhibitor to lower lipid levels was linked with significantly better survival in patients ...
(MedPage Today) -- Use of a PCSK9 inhibitor to lower lipid levels was linked with significantly better survival in patients ...
(MedPage Today) -- Adverse drug effects among patients under treatment for autoimmune rheumatologic disorders stemmed more often from ancillary medications ...
(MedPage Today) -- The FDA approved the first-in-class oral aldosterone synthase inhibitor baxdrostat (Baxfendy) to treat adults with uncontrolled hypertension ...
(MedPage Today) -- Over the past few years, some dedicated physicians and other emergency department team members have created a ...
(MedPage Today) -- The FDA on Wednesday approved a new all-oral regimen for newly diagnosed acute myeloid leukemia (AML) in ...
(MedPage Today) -- A 74-year-old falls while using a walker. Rather than being a protective factor, the walker could be ...
(MedPage Today) -- This article includes a first-person perspective from early breast cancer patient Lina. Lina was compensated for her ...
However, the expenditure in private hospitals was higher in both urban and rural areas, placing the State among those with ...
(MedPage Today) -- Intradialytic oral protein supplementation was linked with improvements in several nutritional markers and real-world outcomes for patients ...
(MedPage Today) -- Older patients represent the group in which cannabis use is increasing most rapidly. The rates of use ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.